BeiGene Ltd (BGNE)
194.56
+0.30
(+0.15%)
USD |
NASDAQ |
Nov 21, 16:00
194.76
+0.20
(+0.10%)
After-Hours: 20:00
BeiGene Net Income (Quarterly): -121.35M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -121.35M |
| June 30, 2024 | -120.40M |
| March 31, 2024 | -251.15M |
| December 31, 2023 | -367.55M |
| September 30, 2023 | 215.41M |
| June 30, 2023 | -381.14M |
| March 31, 2023 | -348.43M |
| December 31, 2022 | -445.34M |
| September 30, 2022 | -557.56M |
| June 30, 2022 | -565.73M |
| March 31, 2022 | -435.20M |
| December 31, 2021 | -590.68M |
| September 30, 2021 | -438.11M |
| June 30, 2021 | -480.34M |
| March 31, 2021 | 66.50M |
| December 31, 2020 | -500.81M |
| September 30, 2020 | -425.22M |
| June 30, 2020 | -335.20M |
| March 31, 2020 | -363.74M |
| December 31, 2019 | -388.06M |
| September 30, 2019 | -307.36M |
| Date | Value |
|---|---|
| June 30, 2019 | -85.57M |
| March 31, 2019 | -167.64M |
| December 31, 2018 | -268.26M |
| September 30, 2018 | -144.03M |
| June 30, 2018 | -156.89M |
| March 31, 2018 | -104.60M |
| December 31, 2017 | -99.32M |
| September 30, 2017 | 117.39M |
| June 30, 2017 | -60.54M |
| March 31, 2017 | -50.62M |
| December 31, 2016 | -37.60M |
| September 30, 2016 | -35.49M |
| June 30, 2016 | -24.12M |
| March 31, 2016 | -22.00M |
| December 31, 2015 | -27.25M |
| September 30, 2015 | -14.00M |
| June 30, 2015 | -5.641M |
| March 31, 2015 | -10.21M |
| December 31, 2014 | -3.751M |
| September 30, 2014 | -9.759M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-590.68M
Minimum
Dec 2021
215.41M
Maximum
Sep 2023
-341.70M
Average
-384.60M
Median
Net Income (Quarterly) Benchmarks
| Theravance Biopharma Inc | -12.70M |
| Merck & Co Inc | 3.157B |
| Bristol-Myers Squibb Co | 1.211B |
| Zai Lab Ltd | -41.67M |
| Halozyme Therapeutics Inc | 137.01M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.002B |
| Total Expenses (Quarterly) | 1.122B |
| EPS Diluted (Quarterly) | -1.17 |
| Enterprise Value | 19.09B |
| Gross Profit Margin (Quarterly) | 82.98% |
| Profit Margin (Quarterly) | -12.12% |
| Earnings Yield | -4.28% |
| Normalized Earnings Yield | -4.276 |